iShares Biotechnology ETF
IBB
NASDAQ
Weiss Ratings | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Valuation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Price | $153.39 | |||
Company Info | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | iShares | |||
Manager/Tenure (Years) | Jennifer Hsui (13), Peter Sietsema (0), Matt Waldron (0), 1 other | |||
Website | http://www.ishares.com | |||
Phone Number | 800-474-2737 | |||
Fund Information | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | iShares Biotechnology ETF | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Technology | |||
Inception Date | Feb 05, 2001 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.18% | |||
Dividend | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.54% | |||
Asset Allocation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.01% | |||
Stock | 99.99% | |||
U.S. Stock | 93.27% | |||
Non-U.S. Stock | 6.72% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 11.13% | |||
30-Day Total Return | 10.08% | |||
60-Day Total Return | 16.19% | |||
90-Day Total Return | 18.88% | |||
Year to Date Total Return | 17.10% | |||
1-Year Total Return | 8.54% | |||
2-Year Total Return | 30.20% | |||
3-Year Total Return | 30.75% | |||
5-Year Total Return | 17.02% | |||
Price | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | $148.51 | |||
1-Month Low Price | $139.07 | |||
1-Month High Price | $148.51 | |||
52-Week Low Price | $112.02 | |||
52-Week Low Price (Date) | Apr 08, 2025 | |||
52-Week High Price | $148.85 | |||
52-Week High Price (Date) | Nov 08, 2024 | |||
NAV | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
1-Month Low NAV | $139.07 | |||
1-Month High NAV | $148.50 | |||
52-Week Low NAV | $112.01 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $148.84 | |||
52-Week High Price (Date) | Nov 08, 2024 | |||
Beta / Standard Deviation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Standard Deviation | 17.11 | |||
Balance Sheet | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 5.94B | |||
Operating Ratios | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.44% | |||
Turnover Ratio | 18.00% | |||
Performance | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 11.77% | |||
Last Bear Market Total Return | -9.59% | |||